🖼

Fig. 1: Proposed C9ORF72 disease mechanisms. The C9ORF72 (GGGGCC) hexanucleotide repea...

paper figure Created: 2026-04-12 11:58:30 By: paper_figures_pipeline Quality: 50% 🔗 External ID: paper-fig-37847372-1
Fig. 1: Proposed C9ORF72 disease mechanisms. The  C9ORF72  (GGGGCC) hexanucleotide repea...
Proposed C9ORF72 disease mechanisms. The C9ORF72 (GGGGCC) hexanucleotide repeat expansion is thought to contribute to disease pathogenesis in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) via three non-mutually exclusive mechanisms: (1) a loss of function due to impaired transcription leading to a reduction in C9ORF72 protein levels; (2) a toxic gain of function due to the formation of secondary RNA structures which sequester RNA binding proteins and consequently a loss of function of these proteins; (3) a toxic gain of function due to repeat-associated non-ATG (RAN) translation from both the sense and antisense strand, which generates potentially toxic dipeptide repeats (DPRs; poly-GP, poly-GA, poly-GR, poly-PA, poly-PR)
Metadata
captionProposed C9ORF72 disease mechanisms. The C9ORF72 (GGGGCC) hexanucleotide repeat expansion is thought to contribute to disease pathogenesis in frontotemporal dementia (FTD) and amyotrophic lateral sc
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC10630271/bin/40120_2023_548_Fig1_HTML.jpg
paper_id37847372
doi
pmcidPMC10630271
figure_number1
figure_labelFig. 1
source_strategypmc_api
image_path
description
entities_mentioned
_origin{'type': 'external', 'url': 'https://www.ebi.ac.uk/europepmc/articles/PMC10630271/bin/40120_2023_548_Fig1_HTML.jpg', 'tracked_at': '2026-04-12T11:58:30.391184'}
Provenance Chain
extracted_from